Prostate cancer (PCa) is an age-related disease. Both activation of oncogenes and loss of tumor suppressor genes have been implicated in PCa development. Our recent work suggests that 15-1ipoxygenase 2 (15-LOX-2), an enzyme that metabolizes membrane phospholipid arachidonic acid (AA), is a functional prostate tumor suppressor. The molecule is abundantly expressed in the adult prostate gland but lost in PCa. 15-LOX-2 re-expression in PCa cells inhibits their proliferation in vitro and tumor development in vivo. How 15-LOX-2 suppresses PCa development is incompletely understood. Newly emerged data from our lab suggests that 15-LOX-2 is a prostate senescence gene. In cultured normal human prostate (NHP) epithelial cells, the mRNA and protein levels of 15-LOX-2 and its splice variants accumulate, preceding the replicative cell senescence. 15-LOX-2 expression in NHP cells in vivo is also correlated with age. Gain-of-function experiments reveal that restoration of 15-LOX-2 or its splice variant expression in PCa cells induces a senescence-like phenotype. Targeted expression of 15-LOX-2 or 15-LOX-2sv-b, a splice variant that lacks AA-metabolizing activity, in transgenic animals causes epithelial alterations associated with oxidative stress and senescence. Loss-of-function experiments using small interfering RNA (siRNA) to transiently knock down 15-LOX-2 expression promotes cell-cycle progression and youthful characteristics in NHP cells. Mechanistic studies suggest that the 15-LOX-2-induced NHP cell senescence is not related to its AA-metabolizing enzymatic activity, but rather to p53- and pl6tpRb-related cell-cycle arrest caused by increased oxidative stress. Based on these findings, we hypothesize that 15-LOX-2 is a prostate senescence gene with tumor suppressive functions and loss of 15-LOX-2 expression may allow cells to escape replicative senescence and thus contributes to PCa development. We further hypothesize that 15-LOX-2-mediated NHP cell senescence may involve cell-cycle arrest caused by increased oxidative stress. We propose the following three Specific Aims to test our hypotheses: 1) To study the role of 15-LOX-2 splice variants in NItP cell senescence: Correlation of their expression with prostate age in vivo; 2) To establish the cause and effect relationship: Studies using transgenic animal models and stable RNAi knockdown; and 3) To dissect the molecular mechanisms of NHP cell senescence mediated by 15-LOX-2 and its splice variants.
These aims will be accomplished by a combination of cell biological, biochemical, and molecular methods, as well as utilizing transgenic animals. Our long-term goal is to utilize the data obtained from this project to develop 15-LOX-2-targeted anti-PCa therapeutics that trigger cell-cycle arrest and senescence.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
1R01AG023374-01A1
Application #
6826196
Study Section
Special Emphasis Panel (ZRG1-UKGD (01))
Program Officer
Bellino, Francis
Project Start
2004-09-01
Project End
2009-07-31
Budget Start
2004-09-01
Budget End
2005-07-31
Support Year
1
Fiscal Year
2004
Total Cost
$295,448
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Internal Medicine/Medicine
Type
Organized Research Units
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Liu, Can; Kelnar, Kevin; Liu, Bigang et al. (2011) The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 17:211-5
Suraneni, M V; Schneider-Broussard, R; Moore, J R et al. (2010) Transgenic expression of 15-lipoxygenase 2 (15-LOX2) in mouse prostate leads to hyperplasia and cell senescence. Oncogene 29:4261-75
Jeter, Collene R; Badeaux, Mark; Choy, Grace et al. (2009) Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 27:993-1005
Li, Hangwen; Jiang, Ming; Honorio, Sofia et al. (2009) Methodologies in assaying prostate cancer stem cells. Methods Mol Biol 568:85-138
Chen, Xin; Schneider-Broussard, Robin; Hollowell, Debra et al. (2009) Abnormal differentiation, hyperplasia and embryonic/perinatal lethality in BK5-T/t transgenic mice. Differentiation 77:324-34
Chandra, Dhyan; Tang, Dean G (2009) Detection of apoptosis in cell-free systems. Methods Mol Biol 559:65-75
Bhatia, Bobby; Jiang, Ming; Suraneni, Mahipal et al. (2008) Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells. J Biol Chem 283:27957-72
Bhatia, Bobby; Multani, Asha S; Patrawala, Lubna et al. (2008) Evidence that senescent human prostate epithelial cells enhance tumorigenicity: cell fusion as a potential mechanism and inhibition by p16INK4a and hTERT. Int J Cancer 122:1483-95
Li, Hangwen; Chen, Xin; Calhoun-Davis, Tammy et al. (2008) PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res 68:1820-5
Patrawala, Lubna; Calhoun-Davis, Tammy; Schneider-Broussard, Robin et al. (2007) Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Res 67:6796-805

Showing the most recent 10 out of 19 publications